Literature DB >> 20113936

Impact of obesity on outcomes after open surgical and endovascular abdominal aortic aneurysm repair.

Owen N Johnson1, Anton N Sidawy, James M Scanlon, Roger Walcott, Subodh Arora, Robyn A Macsata, Richard L Amdur, William G Henderson.   

Abstract

BACKGROUND: This study examined impact of obesity on outcomes after abdominal aortic aneurysm repair. STUDY
DESIGN: Data were obtained from the Veterans Affairs National Surgical Quality Improvement Program. Body mass index (BMI) was categorized according to National Institutes of Health guidelines. Multivariate regression adjusted for 40 other risk factors to analyze trends in complications and death within 30 days.
RESULTS: We identified 2,201 patients undergoing 1,185 open and 1,016 endovascular aneurysm repairs (EVAR) for abdominal aortic aneurysms from January 2004 through December 2005. BMI distribution was identical in both groups and reflected national population statistics: approximately 30% were normal (BMI 18.5 to 24.9), 40% were overweight (25.0 to 29.9), and 30% were obese class I (30.0 to 34.9), II (35.0 to 39.9), or III (>/=40.0). After open repair, obesity of any class was independently predictive of wound complications (adjusted odds ratio = 2.4; 95% CI, 1.5 to 5.3; p = 0.002). Class III obesity was also an independent predictor or renal complications (adjusted odds rato = 6.3; 95% CI, 2.2 to 18.0; p < 0.0001) and cardiac complications (adjusted odds ratio = 4.5; 95% CI, 1.1 to 22.9; p = 0.045. After EVAR, obesity (any class) was predictive of wound complications (adjusted odds ratio = 3.1; 95% CI, 1.1 to 8.1; p = 0.026), but not predictive of other complications or death. Between the two types of operation, there were fewer complications and deaths after EVAR compared with open repair across all BMI categories, but outcomes were most disparate among the obese.
CONCLUSIONS: Obesity is an independent risk factor that surgeons should consider during patient selection and operative planning for abdominal aortic aneurysm repair. Obese patients appear to particularly benefit from successful EVAR over open repair, but if open repair is required, special attention should be paid to cardiac risk, perioperative renal protection, and aggresive wound infection prevention measures.

Entities:  

Mesh:

Year:  2009        PMID: 20113936     DOI: 10.1016/j.jamcollsurg.2009.10.011

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Obesity is a predictor of morbidity in 1,629 patients who underwent adrenalectomy.

Authors:  Hadiza S Kazaure; Sanziana A Roman; Julie A Sosa
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

2.  The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007.

Authors:  Kristina A Giles; Mark C Wyers; Frank B Pomposelli; Allen D Hamdan; Y Avery Ching; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2010-09-16       Impact factor: 4.268

3.  New Measures, Old Conclusions: Obesity Does Not Worsen Outcomes after Elective Abdominal Aortic Aneurysm Repair.

Authors:  Joshua John Sommerville Wall; Katie F Boag; Mohammed A Waduud; Keleabetswe Pabale; Benjamin Wood; Marc Bailey; Julian A Scott
Journal:  Aorta (Stamford)       Date:  2022-05-31

4.  Impact of Body Mass Index on Outcomes after Mesenteric Revascularization for Chronic Mesenteric Ischemia.

Authors:  Neel A Mansukhani; Katherine E Hekman; Dustin Y Yoon; Irene B Helenowski; Andrew W Hoel; Heron E Rodriguez; William H Pearce; Mark K Eskandari; Tadaki M Tomita
Journal:  Ann Vasc Surg       Date:  2017-12-05       Impact factor: 1.466

5.  Metabolic syndrome and outcomes after renal intervention.

Authors:  Daynene Vykoukal; Mark G Davies
Journal:  Cardiol Res Pract       Date:  2010-12-27       Impact factor: 1.866

6.  Short-term Mortality and Postoperative Complications of Abdominal Aortic Aneurysm Repair in Obese versus Non-obese Patients.

Authors:  Bo Zonneveld; Duyen Vu; Isabella Kardys; Bas M van Dalen; Sanne M Snelder
Journal:  J Obes Metab Syndr       Date:  2021-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.